top of page

Ian's new Paper in Cells.

Updated: Apr 13, 2023

The continuously increasing association of Alzheimer’s disease (AD) with increased mortality rates indicates an unmet medical need and the critical need for establishing novel molecular targets for therapeutic potential. Agonists for peroxisomal proliferator activating receptors (PPAR) are known to regulate energy in the body and have shown positive effects against Alzheimer’s disease.

Download PDF • 7.23MB


bottom of page